RSC Advances
Paper
(s, 1H), 7.75–7.8 (m, 2H); 13C NMR (75 MHz, CDCl3): d 54.2, 74%), 281 (14), 266 (41), 252 (10), 239 (32), 236 (19), 209 (21), 208
119.4, 125.7 (2C), 128.0 (2C), 128.1, 128.8 (3C), 129.1 (2C), 130.5, (15), 207 (61), 164 (36), 152 (13), 151 (100), 117 (12), 116 (100), 91
134.7, 148.2; EI-MS m/z: 235 (M+, 22%), 207 (14), 206 (71), 180 (19), 89 (21), 78 (11), 77 (18), 65 (11).
(13), 179 (11), 116 (100), 104 (21), 91 (84), 89 (29), 65 (20), 63 (11).
1-Benzyl-4-(4-chlorophenyl)-1H-1,2,3-triazole (3h).15b White
1-(4-Bromobenzyl)-4-phenyl-1H-1,2,3-triazole (3b).21 White solid; m.p. 125–127 C (hexane–AcOEt); IR (cmꢂ1): 3060, 1481,
ꢀ
solid; m.p. 150–152 C (hexane–AcOEt); IR (cmꢂ1): 3082, 1489, 1222, 1069; H NMR (300 MHz, CDCl3): d 5.57 (s, 2H), 7.3–7.4
1
ꢀ
1
1221, 1073; H NMR (300 MHz, CDCl3): d 5.5 (s, 2H), 7.17 (d, (m, 7H), 7.65 (s, 1H), 7.72 (d, 3J(H,H) ¼ 8.7 Hz, 2H); 13C NMR (75
3J(H,H) ¼ 8.4 Hz, 2H), 7.3–7.35 (m, 1H), 7.4–7.45 (m, 2H), 7.52 MHz, CDCl3): d 54.3, 60.4, 119.5, 126.9 (2C), 128.1 (2C), 128.8,
(d, 3J(H,H) ¼ 8.4 Hz, 2H), 7.7 (s, 1H), 7.8–7.85 (m, 2H); 13C NMR 129.0 (2C), 129.2 (2C), 133.9, 134.5, 147.1; EI-MS m/z: 271 (M+ +
(75 MHz, CDCl3): d 53.5, 119.4, 122.9, 125.7 (2C), 128.3, 128.8 2, 9%), 269 (M+, 26%), 242 (23), 241 (15), 240 (70), 207 (14), 206
(2C), 129.6 (2C), 130.3, 132.3 (2C), 133.6, 148.4; EI-MS m/z: 315 (27), 179 (29), 152 (36), 151 (10), 150 (100), 125 (10), 123 (25), 104
(M+ + 2, 9%), 313 (M+, 10%), 286 (16), 284 (17), 206 (20), 171 (24), (20), 102 (11), 91 (93), 65 (22).
169 (25), 116 (100), 90 (19), 89 (28).
1-(4-Bromobenzyl)-4-(4-chlorophenyl)-1H-1,2,3-triazole (3i).
1-(3-Bromobenzyl)-4-phenyl-1H-1,2,3-triazole (3c).14 White White solid; m.p. 146–150 ꢀC (hexane–AcOEt); IR (cmꢂ1): 1487,
solid; m.p. 85–87 ꢀC (hexane–AcOEt); IR (cmꢂ1): 3084, 1460, 1456, 1227, 1092, 1072; H NMR (300 MHz, CDCl3): d 5.53 (s,
1
1432, 1222, 1046; 1H NMR (300 MHz, CDCl3): d 5.54 (s, 2H), 7.2– 2H), 7.18 (d, J(H,H) ¼ 8.4 Hz, 2H), 7.36 (d, J(H,H) ¼ 8.5 Hz,
7.25 (m, 2H), 7.3–7.35 (m, 1H), 7.4–7.45 (m, 2H), 7.45–7.5 (m, 2H), 7.51 (d, 3J(H,H) ¼ 8.4 Hz, 2H), 7.66 (s, 1H), 7.72 (d, 3J(H,H)
2H), 7.71 (s, 1H), 7.8–7.85 (m, 2H); 13C NMR (75 MHz, CDCl3): d ¼ 8.5 Hz, 2H); 13C NMR (75 MHz, CDCl3): d 53.5, 119.5, 123.0,
53.4, 119.5, 123.1, 125.7 (2C), 126.5, 128.3, 128.8 (2C), 130.2, 126.9 (2C), 128.8, 129.0 (2C), 129.6 (2C), 132.3 (2C), 133.5, 133.9,
130.7, 130.9, 131.9, 136.8, 148.3; EI-MS m/z: 315 (M+ + 2, 8%), 147.3; EI-MS m/z: 349 (M+ + 2, 17%), 347 (M+, 13%), 320 (19), 318
313 (M+, 8%), 286 (14), 284 (14), 206 (21), 171 (22), 169 (23), 116 (14), 240 (26), 207 (10), 171 (27), 169 (29), 152 (33), 151 (10), 150
3
3
(100), 90 (20), 89 (29).
(100), 123 (16), 90 (19), 89 (16); HRMS (ESI): m/z calcd for
1-(2-Bromobenzylꢀ)-4-phenyl-1H-1,2,3-triazole (3d).14 White
C
15H11BrClN3: 346.9825; found: 346.9828.
1-Benzyl-4-(2-chloropehnyl)-1H-1,2,3-triazole (3j).22 White
solid; m.p. 101–103 C (hexane–AcOEt); IR (cmꢂ1): 3051, 1459,
1430, 1220, 1043; 1H NMR (300 MHz, CDCl3): d 5.7 (s, 2H), 7.15– solid; m.p. 77–78 ꢀC (hexane–AcOEt); IR (cmꢂ1): 3083, 1461,
1
7.25 (m, 2H), 7.3–7.35 (m, 2H), 7.4–7.45 (m, 2H), 7.62 (dd, 1227, 1056; H NMR (300 MHz, CDCl3): d 5.61 (s, 2H), 7.2–7.45
4
3
4
3J(H,H) ¼ 7.9 Hz, J(H,H) ¼ 1.0 Hz, 1H), 7.78 (s, 1H), 7.82 (d, (m, 8H), 8.12 (s, 1H), 8.22 (dd, J(H,H) ¼ 7.8 Hz, J(H,H) ¼ 1.8
3J(H,H) ¼ 7.3 Hz, 2H); 13C NMR (75 MHz, CDCl3): d 53.8, 119.8, Hz, 2H); 13C NMR (75 MHz, CDCl3): d 54.2, 123.1, 127.1, 127.9
123.4, 125.7 (2C), 128.2 (2C), 128.8 (2C), 130.1, 130.2, 130.4, (2C), 128.7, 129.0, 129.1 (2C), 129.2, 129.8, 130.1, 131.1, 134.6,
133.2, 134.2, 148.1; EI-MS m/z: 315 (M+ + 2, 12%), 313 (M+, 11%), 144.4; EI-MS m/z: 271 (M+ + 2, 6%), 269 (M+, 17%), 242 (12), 240
208 (12), 207 (59), 206 (93), 184 (11), 171 (31), 169 (32), 117 (11), (36), 206 (40), 179 (30), 152 (28), 150 (87), 123 (14), 104 (26), 102
116 (100), 103 (13), 91 (21), 90 (24), 89 (34), 63 (10).
(10), 91 (100), 65 (19).
1-(2-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole (3e).12h White
1-Benzyl-4-(4-bromophenyl)-1H-1,2,3-triazole (3k).6b White
solid; m.p. 98–99 ꢀC (hexane–AcOEt); IR (cmꢂ1): 3096, 1462, solid; m.p. 143–145 ꢀC (hexane–AcOEt); IR (cmꢂ1): 3070, 1477,
1216; 1H NMR (300 MHz, CDCl3): d 2.31 (s, 3H), 5.6 (s, 2H), 7.2– 1449, 1222, 1050; 1H NMR (300 MHz, CDCl3): d 5.56 (s, 2H), 7.3–
7.25 (m, 3H), 7.3–7.35 (m, 2H), 7.35–7.45 (m, 2H), 7.54 (s, 1H), 7.4 (m, 5H), 7.5–7.55 (m, 2H), 7.65–7.7 (m, 3H); 13C NMR (75
7.75–7.8 (m, 2H); 13C NMR (75 MHz, CDCl3): d 19.0, 52.5, 119.2, MHz, CDCl3): d 54.3, 119.5, 122.0, 127.2 (2C), 128.1 (2C), 128.8,
125.6 (2C), 126.7, 128.1, 128.8 (2C), 129.2, 129.4, 130.5, 131.1, 129.1 (2C), 129.4, 131.9 (2C), 134.4, 147.1; EI-MS m/z: 315 (M+ + 2,
132.5, 137.0, 148.0; EI-MS m/z: 249 (M+, 22%), 220 (35), 207 (17), 23%), 313 (M+, 24%), 287 (10), 286 (54), 285 (11), 284 (53), 207
206 (11), 118 (31), 117 (39), 116 (100), 105 (63), 104 (10), 103 (15), (12), 206 (40), 204 (11), 196 (73), 194 (75), 179 (32), 178 (12), 169
89 (23), 79 (14), 77 (21).
(13), 167 (13), 115 (11), 104 (18), 102 (12), 91 (100), 88 (14), 65 (19).
1-(3-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole (3f).21 White
4-(4-Bromophenyl)-1-(3-methylbenzyl)-1H-1,2,3-triazole (3l).
solid; m.p. 95–96 ꢀC (hexane–AcOEt); IR (cmꢂ1): 3089, 1464, White solid; m.p. 127–128 C (hexane–AcOEt); IR (cmꢂ1): 3016,
ꢀ
1222; 1H NMR (300 MHz, CDCl3): d 2.34 (s, 3H), 5.52 (s, 2H), 7.1– 1450, 1225, 1069; 1H NMR (300 MHz, CDCl3): d 2.35 (s, 3H), 5.53
7.2 (m, 3H), 7.25–7.45 (m, 4H), 7.66 (s, 1H), 7.8–7.85 (m, 2H); 13
C
(s, 2H), 7.11 (d, 3J(H,H) ¼ 7.3 Hz, 2H), 7.18 (d, 3J(H,H) ¼ 7.3 Hz,
NMR (75 MHz, CDCl3): d 21.3, 54.2, 119.5, 125.1, 125.6 (2C), 1H), 7.28 (d, 3J(H,H) ¼ 7.3 Hz, 1H), 7.52 (d, 3J(H,H) ¼ 8.6 Hz, 2H),
128.1, 128.7, 128.8 (2C), 129.0, 129.5, 130.5, 134.5, 139.0, 148.1; 7.65 (s, 1H), 7.67 (d, J(H,H) ¼ 8.6 Hz, 2H); 13C NMR (75 MHz,
3
EI-MS m/z: 249 (M+, 29%), 221 (13), 220 (61), 206 (36), 179 (20), CDCl3): d 21.3, 54.3, 119.5, 122.0, 125.2, 127.2 (2C), 128.8, 129.0,
118 (14), 117 (17), 116 (100), 105 (66), 103 (14), 89 (24), 79 (13), 77 129.5, 129.6, 131.9 (2C), 134.3, 139.1, 147.1; EI-MS m/z: 329 (M+ +
(20).
2, 24%), 327 (M+, 22%), 300 (34), 298 (36), 286 (27), 284 (26), 220
1-(3,5-Dimethoxybenzyl)-4-phenyl-1H-1,2,3-triazole (3g).12h (21), 207 (22), 196 (70), 194 (76), 193 (27), 178 (12), 169 (12), 167
White solid; m.p. 90–92 ꢀC (hexane–AcOEt); IR (cmꢂ1): 3086, (12), 118 (18), 117 (11), 115 (15), 105 (100), 103 (20), 102 (14), 88
1
1610, 1197; H NMR (300 MHz, CDCl3): d 3.76 (s, 6H), 5.49 (s, (15), 79; elemental analysis calcd for C16H14BrN3: C ¼ 58.55; H ¼
2H), 6.44 (s, 3H), 7.3–7.35 (m, 1H), 7.35–7.4 (m, 2H), 7.68 (s, 1H), 4.30; N ¼ 12.80; found: C ¼ 58.50; H ¼ 4.29; N ¼ 12.69.
7.75–7.8 (m, 2H); 13C NMR (75 MHz, CDCl3): d 54.2, 55.4 (2C),
1-Benzyl-4-(4-methoxyphenyl)-1H-1,2,3-triazole
(3m).15b
100.4, 106.0 (2C), 119.5, 125.6 (2C), 128.1, 128.8 (2C), 130.5, White solid; m.p. 135–136 ꢀC (hexane–AcOEt); IR (cmꢂ1):
136.7, 148.2, 161.2 (2C); EI-MS m/z: 296 (M+ + 1, 13%), 295 (M+, 1455, 1250; 1H NMR (300 MHz, CDCl3): d 3.82 (s, 3H), 5.55
23948 | RSC Adv., 2014, 4, 23943–23951
This journal is © The Royal Society of Chemistry 2014